Atlas Trials

Effect of Babaodan on Tumor Recurrence After Curative Resection of Hepatocellular Carcinoma

Clinical trial NCT03515369 · UNKNOWN

Trial details

NCT number
NCT03515369
Sponsor
Eastern Hepatobiliary Surgery Hospital
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Hepatocellular CarcinomaTumor Recurrence
Start date
2018-05-01
Primary completion
2022-01-01
Enrollment
459

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.